Biotech companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of Akebia TherapeuticsLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 21, 2026, FDA's public records list Keryx Biopharmaceuticals with 2 drug recalls. The most recent is a drug recall dated Jul 10, 2020: Auryxia (ferric citrate) tablets 210 mg, Rx Only, 200 tablets per bottle, Manufactured f….
Drug approvals, 510(k) clearances, recalls and letters, 2018 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Jul 10, 2020 | Auryxia (ferric citrate) tablets 210 mg, Rx Only, 200 tablets per bottle, Manufactured for and distributed by: Keryx Biopharmaceuticals…Class II · cGMP deviations: Lots recalled were not manufactured in conformance with the FDA-approved manufacturing process for… | Drug recall |
| Dec 12, 2017 | Auryxia (ferric citrate) tablets, 210 mg , 200-count bottles, RX ONLY, Manufactured for and distributed by: Keryx Biopharmaceticals, Inc.…Class III · Presence of Foreign Substance: Reports have been received of damaged StripPax packets containing silica gel desiccant… | Drug recall |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.